Shares of pharmaceutical giant Merck & Co (MRK) have been trading roughly flat over the past six months following a selloff in shares. One trader sees the potential for a move higher in the coming months.
That’s based on the November $75 calls. With 67 days left on the trade, over 41,300 contracts traded against a prior open interest of 494, for an 84-fold rise in volume. The buyer of the calls paid $1.88 to make the trade.
Shares trade for around $73.50, so shares would need to rise $1.50, or about 2 percent for the trade to move in-the-money. Shares have traded as high as $86 in the past year before a recent selloff, so on a move higher in shares could deliver big returns.
- My #1 EV Stock (NOT Tesla)
I believe this little-known company will be the next EV giant.
Its car is faster than Ferrari's F8, McLaren's 720S and Porsche's 911 Turbo. Yet it's 100% electric.
And while it's a marvel of American engineering...The CEO wants it to be an everyman's car... and plans to ship out 1 million per year.
Already, it's set to grow faster than Tesla, Amazon and Facebook... COMBINED. Sales could DOUBLE to $5.5 billion in 2023... then almost double again to $9.9 billion a year after that.
Simply put, this company could be on the verge of a HUGE run.
The company’s operations have been mixed over the past year, as earnings have fallen by nearly half, but revenue has risen by nearly 22 percent.
Action to take: Shares are going for less than 9 times forward earnings, making for a solid value play for investors. The company also raised its annual dividend from $2.52 to $2.60, making for a 3.5 percent starting yield right now.
Traders may like the November calls, given the amount of time left on the trade, combined with the potential for a jump higher in shares to lead to triple-digit returns on the options.
Disclosure: The author of this article has no position in the company mentioned here, but may trade after the next 72 hours. The author receives no compensation from any of the companies mentioned in this article.